APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pediatric Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pediatric Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174022930320 December 2025190 pages

Choose your research edition.

Industry ResearchPediatric Drugs Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Pediatric Drugs Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Pediatric Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pediatric Drugs Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Pediatric Drugs Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Pediatric Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pediatric Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pediatric Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pediatric Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pediatric Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pediatric Drugs include Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Colgate Oral Pharmaceuticals, Forest Laboratories, Genentech, MedImmune, Novo Nordisk and Pharmacia, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pediatric Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pediatric Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pediatric Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pediatric Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Pediatric Drugs Segment by Company

Abbott Laboratories

Boehringer Ingelheim

Bristol-Myers Squibb

Colgate Oral Pharmaceuticals

Forest Laboratories

Genentech

MedImmune

Novo Nordisk

Pharmacia

Schering-Plough

Bayer

GlaxoSmithKline

Pfizer

Eli Lilly

Roche

Merck

Novartis Pharmaceuticals

Johnson & Johnson

Pediatric Drugs Segment by Type

Cancer Therapies

Allergy and Respiratory Drugs

Hormone Drugs

Anti-Infectives

Urological Drugs

Gastrointestinal Drugs

Cardiovascular Drugs

Central Nervous System Drugs

Pediatric Drugs Segment by Application

Hospital

Clinic

Drugstore

Pediatric Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pediatric Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pediatric Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pediatric Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pediatric Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pediatric Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pediatric Drugs Industry Trends Table 2. Pediatric Drugs Industry Drivers Table 3. Pediatric Drugs Industry Opportunities and Challenges Table 4. Pediatric Drugs Industry Restraints Table 5. Global Pediatric Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pediatric Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pediatric Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Pediatric Drugs Sales Market Share by Manufacturers Table 9. Global Pediatric Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Pediatric Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pediatric Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pediatric Drugs Manufacturers, Product Type & Application Table 13. Global Pediatric Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pediatric Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Cancer Therapies Table 17. Major Manufacturers of Allergy and Respiratory Drugs Table 18. Major Manufacturers of Hormone Drugs Table 19. Major Manufacturers of Anti-Infectives Table 20. Major Manufacturers of Urological Drugs Table 21. Major Manufacturers of Gastrointestinal Drugs Table 22. Major Manufacturers of Cardiovascular Drugs Table 23. Major Manufacturers of Central Nervous System Drugs Table 24. Global Pediatric Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Pediatric Drugs Sales by Type (2021-2026) & (K Units) Table 26. Global Pediatric Drugs Sales by Type (2027-2032) & (K Units) Table 27. Global Pediatric Drugs Sales Market Share by Type (2021-2026) Table 28. Global Pediatric Drugs Sales Market Share by Type (2027-2032) Table 29. Global Pediatric Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 30. Global Pediatric Drugs Revenue by Type (2021-2026) & (K Units) Table 31. Global Pediatric Drugs Revenue by Type (2027-2032) & (K Units) Table 32. Global Pediatric Drugs Revenue Market Share by Type (2021-2026) Table 33. Global Pediatric Drugs Revenue Market Share by Type (2027-2032) Table 34. Major Manufacturers of Hospital Table 35. Major Manufacturers of Clinic Table 36. Major Manufacturers of Drugstore Table 37. Global Pediatric Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Pediatric Drugs Sales by Application (2021-2026) & (K Units) Table 39. Global Pediatric Drugs Sales by Application (2027-2032) & (K Units) Table 40. Global Pediatric Drugs Sales Market Share by Application (2021-2026) Table 41. Global Pediatric Drugs Sales Market Share by Application (2027-2032) Table 42. Global Pediatric Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 43. Global Pediatric Drugs Revenue by Application (2021-2026) & (K Units) Table 44. Global Pediatric Drugs Revenue by Application (2027-2032) & (K Units) Table 45. Global Pediatric Drugs Revenue Market Share by Application (2021-2026) Table 46. Global Pediatric Drugs Revenue Market Share by Application (2027-2032) Table 47. Global Pediatric Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Pediatric Drugs Sales by Region (2021-2026) & (K Units) Table 49. Global Pediatric Drugs Sales Market Share by Region (2021-2026) Table 50. Global Pediatric Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 51. Global Pediatric Drugs Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Pediatric Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. North America Pediatric Drugs Sales by Country (2021-2026) & (K Units) Table 54. North America Pediatric Drugs Sales by Country (2027-2032) & (K Units) Table 55. Europe Pediatric Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Europe Pediatric Drugs Sales by Country (2021-2026) & (K Units) Table 57. Europe Pediatric Drugs Sales by Country (2027-2032) & (K Units) Table 58. Asia Pacific Pediatric Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Asia Pacific Pediatric Drugs Sales by Country (2021-2026) & (K Units) Table 60. Asia Pacific Pediatric Drugs Sales by Country (2027-2032) & (K Units) Table 61. South America, Middle East and Africa Pediatric Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 62. South America, Middle East and Africa Pediatric Drugs Sales by Country (2021-2026) & (K Units) Table 63. South America, Middle East and Africa Pediatric Drugs Sales by Country (2027-2032) & (K Units) Table 64. Global Pediatric Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Pediatric Drugs Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Pediatric Drugs Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Pediatric Drugs Revenue Market Share by Region (2021-2026) Table 68. Global Pediatric Drugs Revenue Market Share by Region (2027-2032) Table 69. Abbott Laboratories Company Information Table 70. Abbott Laboratories Business Overview Table 71. Abbott Laboratories Pediatric Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Abbott Laboratories Pediatric Drugs Product Portfolio Table 73. Abbott Laboratories Recent Development Table 74. Boehringer Ingelheim Company Information Table 75. Boehringer Ingelheim Business Overview Table 76. Boehringer Ingelheim Pediatric Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Boehringer Ingelheim Pediatric Drugs Product Portfolio Table 78. Boehringer Ingelheim Recent Development Table 79. Bristol-Myers Squibb Company Information Table 80. Bristol-Myers Squibb Business Overview Table 81. Bristol-Myers Squibb Pediatric Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Bristol-Myers Squibb Pediatric Drugs Product Portfolio Table 83. Bristol-Myers Squibb Recent Development Table 84. Colgate Oral Pharmaceuticals Company Information Table 85. Colgate Oral Pharmaceuticals Business Overview Table 86. Colgate Oral Pharmaceuticals Pediatric Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Colgate Oral Pharmaceuticals Pediatric Drugs Product Portfolio Table 88. Colgate Oral Pharmaceuticals Recent Development Table 89. Forest Laboratories Company Information Table 90. Forest Laboratories Business Overview Table 91. Forest Laboratories Pediatric Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Forest Laboratories Pediatric Drugs Product Portfolio Table 93. Forest Laboratories Recent Development Table 94. Genentech Company Information Table 95. Genentech Business Overview Table 96. Genentech Pediatric Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Genentech Pediatric Drugs Product Portfolio Table 98. Genentech Recent Development Table 99. MedImmune Company Information Table 100. MedImmune Business Overview Table 101. MedImmune Pediatric Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. MedImmune Pediatric Drugs Product Portfolio Table 103. MedImmune Recent Development Table 104. Novo Nordisk Company Information Table 105. Novo Nordisk Business Overview Table 106. Novo Nordisk Pediatric Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Novo Nordisk Pediatric Drugs Product Portfolio Table 108. Novo Nordisk Recent Development Table 109. Pharmacia Company Information Table 110. Pharmacia Business Overview Table 111. Pharmacia Pediatric Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Pharmacia Pediatric Drugs Product Portfolio Table 113. Pharmacia Recent Development Table 114. Schering-Plough Company Information Table 115. Schering-Plough Business Overview Table 116. Schering-Plough Pediatric Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Schering-Plough Pediatric Drugs Product Portfolio Table 118. Schering-Plough Recent Development Table 119. Bayer Company Information Table 120. Bayer Business Overview Table 121. Bayer Pediatric Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Bayer Pediatric Drugs Product Portfolio Table 123. Bayer Recent Development Table 124. GlaxoSmithKline Company Information Table 125. GlaxoSmithKline Business Overview Table 126. GlaxoSmithKline Pediatric Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. GlaxoSmithKline Pediatric Drugs Product Portfolio Table 128. GlaxoSmithKline Recent Development Table 129. Pfizer Company Information Table 130. Pfizer Business Overview Table 131. Pfizer Pediatric Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Pfizer Pediatric Drugs Product Portfolio Table 133. Pfizer Recent Development Table 134. Eli Lilly Company Information Table 135. Eli Lilly Business Overview Table 136. Eli Lilly Pediatric Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Eli Lilly Pediatric Drugs Product Portfolio Table 138. Eli Lilly Recent Development Table 139. Roche Company Information Table 140. Roche Business Overview Table 141. Roche Pediatric Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Roche Pediatric Drugs Product Portfolio Table 143. Roche Recent Development Table 144. Merck Company Information Table 145. Merck Business Overview Table 146. Merck Pediatric Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Merck Pediatric Drugs Product Portfolio Table 148. Merck Recent Development Table 149. Novartis Pharmaceuticals Company Information Table 150. Novartis Pharmaceuticals Business Overview Table 151. Novartis Pharmaceuticals Pediatric Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Novartis Pharmaceuticals Pediatric Drugs Product Portfolio Table 153. Novartis Pharmaceuticals Recent Development Table 154. Johnson & Johnson Company Information Table 155. Johnson & Johnson Business Overview Table 156. Johnson & Johnson Pediatric Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Johnson & Johnson Pediatric Drugs Product Portfolio Table 158. Johnson & Johnson Recent Development Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Pediatric Drugs Distributors List Table 162. Pediatric Drugs Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Pediatric Drugs Product Image Figure 2. Global Pediatric Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pediatric Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Pediatric Drugs Sales (2021-2032) & (K Units) Figure 5. Global Pediatric Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pediatric Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Cancer Therapies Image Figure 9. Allergy and Respiratory Drugs Image Figure 10. Hormone Drugs Image Figure 11. Anti-Infectives Image Figure 12. Urological Drugs Image Figure 13. Gastrointestinal Drugs Image Figure 14. Cardiovascular Drugs Image Figure 15. Central Nervous System Drugs Image Figure 16. Global Pediatric Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Pediatric Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 18. Global Pediatric Drugs Sales Market Share by Type (2021-2032) Figure 19. Global Pediatric Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Pediatric Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Pediatric Drugs Revenue Market Share by Type (2021-2032) Figure 22. Hospital Image Figure 23. Clinic Image Figure 24. Drugstore Image Figure 25. Global Pediatric Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Pediatric Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Pediatric Drugs Sales Market Share by Application (2021-2032) Figure 28. Global Pediatric Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 29. Global Pediatric Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Pediatric Drugs Revenue Market Share by Application (2021-2032) Figure 31. North America Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. North America Pediatric Drugs Sales Market Share by Country (2021-2032) Figure 33. U.S. Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Canada Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Mexico Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Europe Pediatric Drugs Sales Market Share by Country (2021-2032) Figure 38. Germany Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. France Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. U.K. Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Italy Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Netherlands Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Asia Pacific Pediatric Drugs Sales Market Share by Country (2021-2032) Figure 45. China Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Japan Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Korea Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Southeast Asia Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. India Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Australia Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South America, Middle East and Africa Pediatric Drugs Sales Market Share by Country (2021-2032) Figure 53. Brazil Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. South Africa Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Saudi Arabia Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Turkey Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Argentina Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. UAE Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Egypt Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Chile Pediatric Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 61. Global Pediatric Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Pediatric Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Pediatric Drugs Revenue (2021-2032) & (US$ Million) Figure 64. North America Pediatric Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Pediatric Drugs Revenue (2021-2032) & (US$ Million) Figure 66. Europe Pediatric Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Pediatric Drugs Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Pediatric Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Pediatric Drugs Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Pediatric Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Pediatric Drugs Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Pediatric Drugs Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Cancer Therapies
  • Allergy and Respiratory Drugs
  • Hormone Drugs
  • Anti-Infectives
  • Urological Drugs
  • Gastrointestinal Drugs
  • Cardiovascular Drugs
  • Central Nervous System Drugs
Applications
  • Hospital
  • Clinic
  • Drugstore
Companies covered
  • Abbott Laboratories
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Colgate Oral Pharmaceuticals
  • Forest Laboratories
  • Genentech
  • MedImmune
  • Novo Nordisk
  • Pharmacia
  • Schering-Plough
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly
  • Roche
  • Merck
  • Novartis Pharmaceuticals
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pediatric Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pediatric Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pediatric Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pediatric Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pediatric Drugs Market Dynamics
  1. 2.1 Pediatric Drugs Industry Trends
  2. 2.2 Pediatric Drugs Industry Drivers
  3. 2.3 Pediatric Drugs Industry Opportunities and Challenges
  4. 2.4 Pediatric Drugs Industry Restraints
3 Pediatric Drugs Market by Manufacturers
  1. 3.1 Global Pediatric Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pediatric Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pediatric Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pediatric Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pediatric Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pediatric Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Pediatric Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pediatric Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pediatric Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pediatric Drugs Tier 1, Tier 2, and Tier 3
4 Pediatric Drugs Market by Type
  1. 4.1 Pediatric Drugs Type Introduction
  2. 4.1.1 Cancer Therapies
  3. 4.1.2 Allergy and Respiratory Drugs
  4. 4.1.3 Hormone Drugs
  5. 4.1.4 Anti-Infectives
  6. 4.1.5 Urological Drugs
  7. 4.1.6 Gastrointestinal Drugs
  8. 4.1.7 Cardiovascular Drugs
  9. 4.1.8 Central Nervous System Drugs
  10. 4.2 Global Pediatric Drugs Sales by Type
  11. 4.2.1 Global Pediatric Drugs Sales by Type (2021 VS 2025 VS 2032)
  12. 4.2.2 Global Pediatric Drugs Sales by Type (2021-2032)
  13. 4.2.3 Global Pediatric Drugs Sales Market Share by Type (2021-2032)
  14. 4.3 Global Pediatric Drugs Revenue by Type
  15. 4.3.1 Global Pediatric Drugs Revenue by Type (2021 VS 2025 VS 2032)
  16. 4.3.2 Global Pediatric Drugs Revenue by Type (2021-2032)
  17. 4.3.3 Global Pediatric Drugs Revenue Market Share by Type (2021-2032)
5 Pediatric Drugs Market by Application
  1. 5.1 Pediatric Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Drugstore
  5. 5.2 Global Pediatric Drugs Sales by Application
  6. 5.2.1 Global Pediatric Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pediatric Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Pediatric Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pediatric Drugs Revenue by Application
  10. 5.3.1 Global Pediatric Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pediatric Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Pediatric Drugs Revenue Market Share by Application (2021-2032)
6 Global Pediatric Drugs Sales by Region
  1. 6.1 Global Pediatric Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pediatric Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Pediatric Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Pediatric Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pediatric Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pediatric Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pediatric Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pediatric Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pediatric Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pediatric Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pediatric Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pediatric Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pediatric Drugs Revenue by Region
  1. 7.1 Global Pediatric Drugs Revenue by Region
  2. 7.1.1 Global Pediatric Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pediatric Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Pediatric Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Pediatric Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pediatric Drugs Revenue (2021-2032)
  8. 7.2.2 North America Pediatric Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pediatric Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Pediatric Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pediatric Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pediatric Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pediatric Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pediatric Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Pediatric Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Pediatric Drugs Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim Pediatric Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim Pediatric Drugs Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 Bristol-Myers Squibb
  14. 8.3.1 Bristol-Myers Squibb Company Information
  15. 8.3.2 Bristol-Myers Squibb Business Overview
  16. 8.3.3 Bristol-Myers Squibb Pediatric Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bristol-Myers Squibb Pediatric Drugs Product Portfolio
  18. 8.3.5 Bristol-Myers Squibb Recent Developments
  19. 8.4 Colgate Oral Pharmaceuticals
  20. 8.4.1 Colgate Oral Pharmaceuticals Company Information
  21. 8.4.2 Colgate Oral Pharmaceuticals Business Overview
  22. 8.4.3 Colgate Oral Pharmaceuticals Pediatric Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Colgate Oral Pharmaceuticals Pediatric Drugs Product Portfolio
  24. 8.4.5 Colgate Oral Pharmaceuticals Recent Developments
  25. 8.5 Forest Laboratories
  26. 8.5.1 Forest Laboratories Company Information
  27. 8.5.2 Forest Laboratories Business Overview
  28. 8.5.3 Forest Laboratories Pediatric Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Forest Laboratories Pediatric Drugs Product Portfolio
  30. 8.5.5 Forest Laboratories Recent Developments
  31. 8.6 Genentech
  32. 8.6.1 Genentech Company Information
  33. 8.6.2 Genentech Business Overview
  34. 8.6.3 Genentech Pediatric Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Genentech Pediatric Drugs Product Portfolio
  36. 8.6.5 Genentech Recent Developments
  37. 8.7 MedImmune
  38. 8.7.1 MedImmune Company Information
  39. 8.7.2 MedImmune Business Overview
  40. 8.7.3 MedImmune Pediatric Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 MedImmune Pediatric Drugs Product Portfolio
  42. 8.7.5 MedImmune Recent Developments
  43. 8.8 Novo Nordisk
  44. 8.8.1 Novo Nordisk Company Information
  45. 8.8.2 Novo Nordisk Business Overview
  46. 8.8.3 Novo Nordisk Pediatric Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Novo Nordisk Pediatric Drugs Product Portfolio
  48. 8.8.5 Novo Nordisk Recent Developments
  49. 8.9 Pharmacia
  50. 8.9.1 Pharmacia Company Information
  51. 8.9.2 Pharmacia Business Overview
  52. 8.9.3 Pharmacia Pediatric Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pharmacia Pediatric Drugs Product Portfolio
  54. 8.9.5 Pharmacia Recent Developments
  55. 8.10 Schering-Plough
  56. 8.10.1 Schering-Plough Company Information
  57. 8.10.2 Schering-Plough Business Overview
  58. 8.10.3 Schering-Plough Pediatric Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Schering-Plough Pediatric Drugs Product Portfolio
  60. 8.10.5 Schering-Plough Recent Developments
  61. 8.11 Bayer
  62. 8.11.1 Bayer Company Information
  63. 8.11.2 Bayer Business Overview
  64. 8.11.3 Bayer Pediatric Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bayer Pediatric Drugs Product Portfolio
  66. 8.11.5 Bayer Recent Developments
  67. 8.12 GlaxoSmithKline
  68. 8.12.1 GlaxoSmithKline Company Information
  69. 8.12.2 GlaxoSmithKline Business Overview
  70. 8.12.3 GlaxoSmithKline Pediatric Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 GlaxoSmithKline Pediatric Drugs Product Portfolio
  72. 8.12.5 GlaxoSmithKline Recent Developments
  73. 8.13 Pfizer
  74. 8.13.1 Pfizer Company Information
  75. 8.13.2 Pfizer Business Overview
  76. 8.13.3 Pfizer Pediatric Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Pfizer Pediatric Drugs Product Portfolio
  78. 8.13.5 Pfizer Recent Developments
  79. 8.14 Eli Lilly
  80. 8.14.1 Eli Lilly Company Information
  81. 8.14.2 Eli Lilly Business Overview
  82. 8.14.3 Eli Lilly Pediatric Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Eli Lilly Pediatric Drugs Product Portfolio
  84. 8.14.5 Eli Lilly Recent Developments
  85. 8.15 Roche
  86. 8.15.1 Roche Company Information
  87. 8.15.2 Roche Business Overview
  88. 8.15.3 Roche Pediatric Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Roche Pediatric Drugs Product Portfolio
  90. 8.15.5 Roche Recent Developments
  91. 8.16 Merck
  92. 8.16.1 Merck Company Information
  93. 8.16.2 Merck Business Overview
  94. 8.16.3 Merck Pediatric Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Merck Pediatric Drugs Product Portfolio
  96. 8.16.5 Merck Recent Developments
  97. 8.17 Novartis Pharmaceuticals
  98. 8.17.1 Novartis Pharmaceuticals Company Information
  99. 8.17.2 Novartis Pharmaceuticals Business Overview
  100. 8.17.3 Novartis Pharmaceuticals Pediatric Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Novartis Pharmaceuticals Pediatric Drugs Product Portfolio
  102. 8.17.5 Novartis Pharmaceuticals Recent Developments
  103. 8.18 Johnson & Johnson
  104. 8.18.1 Johnson & Johnson Company Information
  105. 8.18.2 Johnson & Johnson Business Overview
  106. 8.18.3 Johnson & Johnson Pediatric Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Johnson & Johnson Pediatric Drugs Product Portfolio
  108. 8.18.5 Johnson & Johnson Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pediatric Drugs Value Chain Analysis
  2. 9.1.1 Pediatric Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pediatric Drugs Production Mode & Process
  6. 9.2 Pediatric Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pediatric Drugs Distributors
  9. 9.2.3 Pediatric Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst